Therapy of Human Rabies

Advances in Virus Research

Volumn 79, Issue , 2011, Pages 365-375

  Jackson, Alan C ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Amantadine; Hypothermia; Ketamine; Rabies; Ribavirin; Therapeutic coma

Indexed keywords

ANTIVIRUS AGENT;

BOOK; HUMAN; IMMUNIZATION; METHODOLOGY; POST EXPOSURE PROPHYLAXIS; RABIES;

ANTIVIRAL AGENTS; HUMANS; IMMUNIZATION; POST-EXPOSURE PROPHYLAXIS; RABIES;

EID: 79956125236     PISSN: 00653527     EISSN: 15578399     Source Type: Book Series    
DOI: 10.1016/B978-0-12-387040-7.00017-2     Document Type: Book

References (51)

1. Badillo R., Mantilla J.C., Pradilla G. Human rabies encephalitis by a vampire bat bite in an urban area of Colombia (Spanish). Biomédica 2009, 29:191-203.
2. Bagchi S. Coma Therapy 2005, The Telegraph, Calcutta., July 4, 2005.
3. Basgoz N., Frosch M.P. Case records of the Massachusetts General Hospital: A 32-year-old woman with pharyngeal spasms and paresthesias after a dog bite. N. Engl. J. Med. 1998, 339:105-112.
4. Bernard S.A., Gray T.W., Buist M.D., Jones B.M., Silvester W., Gutteridge G., Smith K. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N. Engl. J. Med. 2002, 346:557-563.
5. Bisby M.A., Jones D.L. Temperature sensitivity of axonal transport in hibernating and nonhibernating rodents. Exp. Neurol. 1978, 61:74-83.
6. Busch H.J., Eichwede F., Fodisch M., Taccone F.S., Wobker G., Schwab T., Hopf H.B., Tonner P., Hachimi-Idrissi S., Martens P., Fritz H., Bode C., et al. Safety and feasibility of nasopharyngeal evaporative cooling in the emergency department setting in survivors of cardiac arrest. Resuscitation 2010, 81:943-949.
7. Castren M., Nordberg P., Svensson L., Taccone F., Vincent J.L., Desruelles D., Eichwede F., Mols P., Schwab T., Vergnion M., Storm C., Pesenti A., et al. Intra-arrest transnasal evaporative cooling: A randomized, prehospital, multicenter study (PRINCE: Pre-ROSC IntraNasal Cooling Effectiveness). Circulation 2010, 122:729-736.
8. Christenson J.C., Holm B.M., Lechlitner S., Howell J.F., Wenger M., Roy-Burman A., Hsieh C.J., LaBar L., Petru A., Davis S., Simons N., Apolinario P., et al. Human rabies-Indiana and California, 2006. MMWR Morb. Mortal. Wkly. Rep. 2007, 56:361-365.
9. Christian E., Zada G., Sung G., Giannotta S.L. A review of selective hypothermia in the management of traumatic brain injury. Neurosurg. Focus 2008, 25:E9.
10. Darman J., Backovic S., Dike S., Maragakis N.J., Krishnan C., Rothstein J.D., Irani D.N., Kerr D.A. Viral-induced spinal motor neuron death is non-cell-autonomous and involves glutamate excitotoxicity. J. Neurosci. 2004, 24:7566-7575.
11. Drosten C. Rabies - Germany (Hamburg) ex Morocco ProMED-mail 20070419.1287. Available at, Accessed December 4, 2010. http://www.promedmail.org/.
12. Emmons R.W., Leonard L.L., DeGenaro F., Protas E.S., Bazeley P.L., Giammona S.T., Sturckow K. A case of human rabies with prolonged survival. Intervirology 1973, 1:60-72.
13. Ginsberg M.D. Current status of neuroprotection for cerebral ischemia: Synoptic overview. Stroke 2009, 40(Suppl. 3):S111-S114.
14. Hattwick M.A.W., Weis T.T., Stechschulte C.J., Baer G.M., Gregg M.B. Recovery from rabies: A case report. Ann. Intern. Med. 1972, 76:931-942.
15. Hattwick M.A., Corey L., Creech W.B. Clinical use of human globulin immune to rabies virus. J. Infect. Dis. 1976, 133(Suppl.):A266-A272.
16. Hemachudha T., Sunsaneewitayakul B., Mitrabhakdi E., Suankratay C., Laothamathas J., Wacharapluesadee S., Khawplod P., Wilde H. Paralytic complications following intravenous rabies immune globulin treatment in a patient with furious rabies. Int. J. Infect. Dis. 2003, 7:76-77. (Letter).
17. Hemachudha T., Sunsaneewitayakul B., Desudchit T., Suankratay C., Sittipunt C., Wacharapluesadee S., Khawplod P., Wilde H., Jackson A.C. Failure of therapeutic coma and ketamine for therapy of human rabies. J. Neurovirol. 2006, 12:407-409.
18. Rabies, human-USA (Texas) Houston Chronicle, ProMED-mail 20060513.1360. Available at, Accessed December 4, 2010. http://www.promedmail.org/.
19. Hu W.T., Willoughby R.E., Dhonau H., Mack K.J. Long-term follow-up after treatment of rabies by induction of coma. N. Engl. J. Med. 2007, 357:945-946. (Letter).
20. Hunter M., Johnson N., Hedderwick S., McCaughey C., Lowry K., McConville J., Herron B., McQuaid S., Marston D., Goddard T., Harkess G., Goharriz H., et al. Immunovirological correlates in human rabies treated with therapeutic coma. J. Med. Virol. 2010, 82:1255-1265.
21. Jackson A.C. Recovery from rabies. N. Engl. J. Med. 2005, 352:2549-2550. (Editorial).
22. Jackson A.C., Warrell M.J., Rupprecht C.E., Ertl H.C.J., Dietzschold B., O'Reilly M., Leach R.P., Fu Z.F., Wunner W.H., Bleck T.P., Wilde H. Management of rabies in humans. Clin. Infect. Dis. 2003, 36:60-63.
23. Juncosa B. Hope for rabies victims: Unorthodox coma therapy shows promise. First a U.S. girl-And now two South American kids survive onset of the deadly virus Scientific American.com. Available at, Accessed December 4, 2010. http://www.scientificamerican.com/.
24. Kaul M., Lipton S.A. Neuroinflammation and excitotoxicity in neurobiology of HIV-1 infection and AIDS: Targets for neuroprotection. Interaction Between Neurons and Glia in Aging and Disease 2007, 281-308. Springer Science, New York. J.O. Malva, A.C. Rego, R.A. Cunha, C.R. Oliveira (Eds.).
25. Kureishi A., Xu L.Z., Wu H., Stiver H.G. Rabies in China: Recommendations for control. Bull. World Health Organ. 1992, 70:443-450.
26. Lafon M. Bat rabies-The Achilles heel of a viral killer?. Lancet 2005, 366:876-877.
27. Lafon M. Immunology. Rabies 2007, 489-504. Elsevier Academic Press, London. A.C. Jackson, W.H. Wunner (Eds.).
28. Lockhart B.P., Tsiang H., Ceccaldi P.E., Guillemer S. Ketamine-mediated inhibition of rabies virus infection in vitro and in rat brain. Antivir. Chem. Chemother. 1991, 2:9-15.
29. Maier T., Schwarting A., Mauer D., Ross R.S., Martens A., Kliem V., Wahl J., Panning M., Baumgarte S., Muller T., Pfefferle S., Ebel H., et al. Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus. Clin. Infect. Dis. 2010, 50:1112-1119.
30. Manning S.E., Rupprecht C.E., Fishbein D., Hanlon C.A., Lumlertdacha B., Guerra M., Meltzer M.I., Dhankhar P., Vaidya S.A., Jenkins S.R., Sun B., Hull H.F. Human rabies prevention-United States, 2008: Recommendations of the Advisory Committee on Immunization Practices. MMWR. Morb. Mortal. Wkly. Rep. 2008, 57(No. RR-3):1-28.
31. McDermid R.C., Saxinger L., Lee B., Johnstone J., Noel Gibney R.T., Johnson M., Bagshaw S.M. Human rabies encephalitis following bat exposure: Failure of therapeutic coma. Can. Med. Assoc. J. 2008, 178:557-561.
32. Merigan T.C., Baer G.M., Winkler W.G., Bernard K.W., Gibert C.G., Chany C., Veronesi R., Collaborative Group Human leukocyte interferon administration to patients with symptomatic and suspected rabies. Ann. Neurol. 1984, 16:82-87.
33. Rabies, human survival, bat-Brazil: (Pernambuco) Ministerio da Saude in Brazil, ProMED-mail 20081114.3599. Available at, Accessed December 4, 2010. http://www.promedmail.org/.
34. Morimoto K., Patel M., Corisdeo S., Hooper D.C., Fu Z.F., Rupprecht C.E., Koprowski H., Dietzschold B. Characterization of a unique variant of bat rabies virus responsible for newly emerging human cases in North America. Proc. Natl Acad. Sci. USA 1996, 93:5653-5658.
35. Nargi-Aizenman J.L., Griffin D.E. Sindbis virus-induced neuronal death is both necrotic and apoptotic and is ameliorated by N-methyl-D-aspartate receptor antagonists. J. Virol. 2001, 75:7114-7121.
36. Nargi-Aizenman J.L., Havert M.B., Zhang M., Irani D.N., Rothstein J.D., Griffin D.E. Glutamate receptor antagonists protect from virus-induced neural degeneration. Ann. Neurol. 2004, 55:541-549.
37. Pue H.L., Turabelidze G., Patrick S., Grim A., Bell C., Reese V., Basilan R., Rupprecht C., Robertson K. Human rabies-Missouri, 2008. MMWR Morb. Mortal. Wkly. Rep. 2009, 58:1207-1209.
38. Rubin J., David D., Willoughby R.E., Rupprecht C.E., Garcia C., Guarda D.C., Zohar Z., Stamler A. Applying the Milwaukee Protocol to treat canine rabies in Equatorial Guinea. Scand. J. Infect. Dis. 2009, 41:372-375.
39. Rupprecht C.E., Briggs D., Brown C.M., Franka R., Katz S.L., Kerr H.D., Lett S.M., Levin R., Meltzer M.I., Schaffner W., Cieslak P.R. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: Recommendations of the advisory committee on immunization practices. MMWR Recomm. Rep. 2010, 59:1-9.
40. Sulkin S.E., Allen R., Sims R., Krutzsch P.H., Kim C. Studies on the pathogenesis of rabies in bats. II. Influence of environmental temperature. J. Exp. Med. 1960, 112:595-617.
41. Superti F., Seganti L., Pana A., Orsi N. Effect of amantadine on rhabdovirus infection. Drugs Exp. Clin. Res. 1985, 11:69-74.
42. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N. Engl. J. Med. 2002, 346:549-556. The Hypothermia After Cardiac Arrest Study Group.
43. Troell P., Miller-Zuber B., Ondrush J., Murphy J., Fatteh N., Feldman K., Mitchell K., Willoughby R., Glymph C., Blanton J., Rupprecht C. Human rabies-Virginia, 2009. MMWR Morb. Mortal. Wkly. Rep. 2010, 59:1236-1238.
44. Turabelidze G., Pue H., Grim A., Patrick S. First human rabies case in Missouri in 50 years causes death in outdoorsman. Mo. Med. 2009, 106:417-419.
45. van Thiel P.P., de Bie R.M., Eftimov F., Tepaske R., Zaaijer H.L., van Doornum G.J., Schutten M., Osterhaus A.D., Majoie C.B., Aronica E., Fehlner-Gardiner C., Wandeler A.I., et al. Fatal human rabies due to Duvenhage virus from a bat in Kenya: Failure of treatment with coma-induction, ketamine, and antiviral drugs. PLoS Negl. Trop. Dis. 2009, 3:e428.
46. Wang H., Olivero W., Lanzino G., Elkins W., Rose J., Honings D., Rodde M., Burnham J., Wang D. Rapid and selective cerebral hypothermia achieved using a cooling helmet. J. Neurosurg. 2004, 100:272-277.
47. Warrell M.J., White N.J., Looareesuwan S., Phillips R.E., Suntharasamai P., Chanthavanich P., Riganti M., Fisher-Hoch S.P., Nicholson K.G., Manatsathit S., Vannaphan S., Warrell D.A. Failure of interferon alfa and tribavirin in rabies encephalitis. Br. Med. J. 1989, 299:830-833.
48. Weli S.C., Scott C.A., Ward C.A., Jackson A.C. Rabies virus infection of primary neuronal cultures and adult mice: Failure to demonstrate evidence of excitotoxicity. J. Virol. 2006, 80:10270-10273.
49. Willoughby R.E. Are we getting closer to the treatment of rabies?. Future Virol. 2009, 4:563-570.
50. Willoughby R.E., Tieves K.S., Hoffman G.M., Ghanayem N.S., Amlie-Lefond C.M., Schwabe M.J., Chusid M.J., Rupprecht C.E. Survival after treatment of rabies with induction of coma. N. Engl. J. Med. 2005, 352:2508-2514.
51. WHO Expert Consultation on Rabies: First Report 2005, World Health Organization, World Health Organization, Geneva.